Comparison of Anti-oncotic Effect of TRPM4 Blocking Antibody in Neuron, Astrocyte and Vascular Endothelial Cell Under Hypoxia
In stroke and other neurological diseases, Transient Receptor Potential Melastatin 4 (TRPM4) has been reported to cause oncotic cell death which is due to an excessive influx of sodium ions. Following stroke, hypoxia condition activates TRPM4 channel, and the sodium influx via TRPM4 is further enhan...
Main Authors: | Shunhui Wei, See Wee Low, Charlene Priscilla Poore, Bo Chen, Yahui Gao, Bernd Nilius, Ping Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.562584/full |
Similar Items
-
Binding epitope for recognition of human TRPM4 channel by monoclonal antibody M4M
by: Shunhui Wei, et al.
Published: (2022-11-01) -
TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion
by: Bo Chen, et al.
Published: (2023-05-01) -
Development and characterization of a monoclonal antibody blocking human TRPM4 channel
by: See Wee Low, et al.
Published: (2021-05-01) -
Detection of TRPM6 and TRPM7 Proteins in Normal and Diseased Cardiac Atrial Tissue and Isolated Cardiomyocytes
by: Inga Andriulė, et al.
Published: (2022-11-01) -
Calmodulin Regulates Transient Receptor Potential TRPM3 and TRPM8-Induced Gene Transcription
by: Gerald Thiel, et al.
Published: (2023-04-01)